Log in

NASDAQ:FWP - Forward Pharma A/S Stock Price, Forecast & News

$7.16
-0.04 (-0.56 %)
(As of 02/24/2020 02:45 AM ET)
Today's Range
$6.85
Now: $7.16
$7.30
50-Day Range
$6.22
MA: $6.72
$7.70
52-Week Range
$5.26
Now: $7.16
$11.01
Volume21,150 shs
Average Volume54,574 shs
Market Capitalization$48.64 million
P/E RatioN/A
Dividend YieldN/A
Beta2.46
Forward Pharma A/S operates as a biopharmaceutical company. The company focuses on developing FP187, a proprietary formulation of dimethyl fumarate used for the treatment of various inflammatory and neurological indications. Forward Pharma A/S was founded in 2005 and is headquartered in Copenhagen, Denmark.

Industry, Sector and Symbol

Industry Pharmaceutical preparations
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:FWP
CUSIPN/A
Phone0114533444242

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$1.25 billion
Book Value$12.19 per share

Profitability

Miscellaneous

Employees5
Market Cap$48.64 million
Next Earnings Date4/2/2020 (Estimated)
OptionableNot Optionable

Receive FWP News and Ratings via Email

Sign-up to receive the latest news and ratings for FWP and its competitors with MarketBeat's FREE daily newsletter.


Forward Pharma A/S (NASDAQ:FWP) Frequently Asked Questions

What is Forward Pharma A/S's stock symbol?

Forward Pharma A/S trades on the NASDAQ under the ticker symbol "FWP."

How were Forward Pharma A/S's earnings last quarter?

Forward Pharma A/S (NASDAQ:FWP) posted its quarterly earnings results on Thursday, September, 1st. The biotechnology company reported ($0.32) earnings per share for the quarter, missing the Thomson Reuters' consensus estimate of ($0.26) by $0.06. View Forward Pharma A/S's Earnings History.

When is Forward Pharma A/S's next earnings date?

Forward Pharma A/S is scheduled to release their next quarterly earnings announcement on Thursday, April 2nd 2020. View Earnings Estimates for Forward Pharma A/S.

Has Forward Pharma A/S been receiving favorable news coverage?

Media stories about FWP stock have been trending positive on Monday, according to InfoTrie Sentiment. The research firm scores the sentiment of press coverage by monitoring more than six thousand blog and news sources in real time. The firm ranks coverage of public companies on a scale of negative five to five, with scores nearest to five being the most favorable. Forward Pharma A/S earned a coverage optimism score of 2.6 on InfoTrie's scale. They also assigned news stories about the biotechnology company a news buzz of 10.0 out of 10, indicating that recent press coverage is extremely likely to have an effect on the company's share price in the near term. View News Stories for Forward Pharma A/S.

Are investors shorting Forward Pharma A/S?

Forward Pharma A/S saw a decrease in short interest in the month of January. As of January 31st, there was short interest totalling 3,800 shares, a decrease of 39.7% from the January 15th total of 6,300 shares. Based on an average trading volume of 25,200 shares, the days-to-cover ratio is currently 0.2 days. Approximately 0.2% of the company's stock are short sold. View Forward Pharma A/S's Current Options Chain.

Who are some of Forward Pharma A/S's key competitors?

What other stocks do shareholders of Forward Pharma A/S own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Forward Pharma A/S investors own include Gilead Sciences (GILD), AbbVie (ABBV), NovaBay Pharmaceuticals (NBY), Inovio Pharmaceuticals (INO), SCYNEXIS (SCYX), Celldex Therapeutics (CLDX), Fate Therapeutics (FATE), MOTIF BIO PLC/S (MTFB), Micron Technology (MU) and Novavax (NVAX).

Who are Forward Pharma A/S's key executives?

Forward Pharma A/S's management team includes the folowing people:
  • Mr. Florian Schonharting, Co-Founder & Chairman (Age 50)
  • Dr. Claus Bo Svendsen, CEO & Principal Financial Officer (Age 42)
  • Mr. Thomas Carbone, Principal Accounting Officer (Age 62)

Who are Forward Pharma A/S's major shareholders?

Forward Pharma A/S's stock is owned by many different of institutional and retail investors. Top institutional shareholders include BVF Inc. IL (13.63%) and Newtyn Management LLC (6.28%).

Which major investors are selling Forward Pharma A/S stock?

FWP stock was sold by a variety of institutional investors in the last quarter, including BVF Inc. IL and Newtyn Management LLC.

How do I buy shares of Forward Pharma A/S?

Shares of FWP can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Forward Pharma A/S's stock price today?

One share of FWP stock can currently be purchased for approximately $7.16.

How big of a company is Forward Pharma A/S?

Forward Pharma A/S has a market capitalization of $48.64 million and generates $1.25 billion in revenue each year. Forward Pharma A/S employs 5 workers across the globe.View Additional Information About Forward Pharma A/S.

What is Forward Pharma A/S's official website?

The official website for Forward Pharma A/S is http://www.forward-pharma.com/.

How can I contact Forward Pharma A/S?

Forward Pharma A/S's mailing address is OSTERGADE 24A 1, COPENHAGEN G7, 1100. The biotechnology company can be reached via phone at 0114533444242 or via email at [email protected]


MarketBeat Community Rating for Forward Pharma A/S (NASDAQ FWP)

Community Ranking:  2.8 out of 5 (star star)
Outperform Votes:  267 (Vote Outperform)
Underperform Votes:  206 (Vote Underperform)
Total Votes:  473
MarketBeat's community ratings are surveys of what our community members think about Forward Pharma A/S and other stocks. Vote "Outperform" if you believe FWP will outperform the S&P 500 over the long term. Vote "Underperform" if you believe FWP will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 2/24/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel